Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Meningeal Carcinomatosis × aflutinib × Clear all

Phase

Status

Recruiting 3 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 9 Brain Neoplasms 3 Adenocarcinoma of Lung 2 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Advanced Non-small Cell Lung Cancer 1

Interventions

Pemetrexed 2 pembrolizumab 1 peginterferon alfa-2b 1 osimertinib 1 lorlatinib 1 aflutinib 1 Radiotherapy 1 Interferons 1 Drug Therapy 1 Cyclophosphamide 1 AZD3759 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07348965 2026-01-16

Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis

Guangzhou University of Traditional Chinese Medicine

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡